Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence of Testosterone Cypionate Formulations in Hypogonadal Males
NCT03792477Phase 1Completed
- Sponsor
- Pfizer
- Start
- Jan 2019
- Primary completion
- Apr 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of testosterone cypionate in Hypogonadism (4 arms), sponsored by Pfizer. Primary endpoints: Area Under The Serum Concentration-time Profile From Time 0 to The Last Quantifiable Concentration, Area Under the Serum Concentration-time Profile From Time 0 Extrapolated to Infinite Time and 1 more. Started Jan 2019; status: completed.
02
Drugs
testosterone cypionate
03
Conditions
Hypogonadism
Beyond the preview
Go deeper on NCT03792477.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03792477.